Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon May 01, 2009 11:40am
357 Views
Post# 15959638

RE: The Wall

RE: The Wall

hard to disagree with that Bepando...   I thought this overhang was clearing up...  There are obviously a few good sized sellers that want or need out...  Seems like an opportunity to me... but I have liked it since $2.0

In all sincerity though, except for the company cash position,  this story has gotten progressively better and better,  all while the share price and capilization of the company has all but disintegrated... something has to give.     You simply cant ignore the fact that the core technology is being more widely adopted,  and its turning into real recurring revenue.

However,  we need one or more large tangible deals that resolve the balance sheet concerns.  I dont even want a huge spike higher in the SP.... I would like to see a grind higher on good solid widespread institutional buying.   Then layer-in increased analyst coverage and retail exposure... and this will be an entirely different situation.  

With the stream of shortcomings and delays and disappointments,  its somewhat understandable that guys are standing by their convictions and selling almost regardless of price.  At the end of the day,  despite a lot of great progress, the company has consistently fallen short on promises.     I think that creates opportunities for those of us that have the patience...   and have been given a PLI-labotomy over the last 4 years...     I am gazing blankly at the mirror chanting " I BELIEVE !! "      ..... and we will make money on this.
Bullboard Posts